Frank Lanza
Directeur Financier/CFO chez HARPOON THERAPEUTICS, INC.
Profil
Frank J.
Lanza's current job(s) include Vice President & Controller at Asterias Biotherapeutics, Inc. since 2016 and Chief Financial & Accounting Officer at Harpoon Therapeutics, Inc. since 2019.
Formerly, Mr. Lanza worked as a Controller at Graybug Vision, Inc. from 2016 to 2018, Controller at Resources Global Professionals, Inc. from 2018 to 2019, and Controller at Horizon Pharmaceutical LLC in 2013 and 2014.
Mr. Lanza obtained an undergraduate degree from California State University-East Bay.
Postes actifs de Frank Lanza
| Sociétés | Poste | Début |
|---|---|---|
| ASTERIAS BIOTHERAPEUTICS INC | Comptroller/Controller/Auditor | 01/01/2016 |
| HARPOON THERAPEUTICS, INC. | Directeur Financier/CFO | 15/09/2022 |
Anciens postes connus de Frank Lanza
| Sociétés | Poste | Fin |
|---|---|---|
Resources Global Professionals, Inc.
 Resources Global Professionals, Inc. Miscellaneous Commercial ServicesCommercial Services Resources Global Professionals, Inc. operates as a professional services firm. Its services include finance and accounting, internal audit, human capital, information management, supply chain management, and legal services. The company was founded in 1996 and is headquartered in Irvine, CA. | Comptroller/Controller/Auditor | 01/01/2019 |
| CALCIMEDICA, INC. | Comptroller/Controller/Auditor | 01/01/2018 |
| RAPTOR PHARMACEUTICAL CORP | Directeur Financier/CFO | - |
Formation de Frank Lanza
| California State University-East Bay | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Horizon Pharmaceutical LLC
 Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Horizon Pharmaceutical LLC engages in the development of transformative treatments for people affected by rare and debilitating diseases. It offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults and for six years and older children. The company was founded by Christopher M. Starr and Todd C. Zankel on April 29, 2002 and is headquartered in Novato, CA. | Health Technology |
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The firm utilizes its proprietary Tri-specific T cell Activating Construct platform to create a pipeline of novel TriTACs for the treatment of solid tumors and hematologic malignancies. The company was founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA. | Health Technology |
Resources Global Professionals, Inc.
Resources Global Professionals, Inc. Miscellaneous Commercial ServicesCommercial Services Resources Global Professionals, Inc. operates as a professional services firm. Its services include finance and accounting, internal audit, human capital, information management, supply chain management, and legal services. The company was founded in 1996 and is headquartered in Irvine, CA. | Commercial Services |
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Graybug Vision, Inc. develops ophthalmic drugs. It focus on developing drug delivery therapies for the treatment of eye diseases such as age-related macular degeneration and glaucoma. The company was founded by Justin S. Hanes, Peter John McDonnell, Christy Wyskiel and Peter A. Campochiaro in May 2011 and is headquartered in Redwood City, CA. | Health Technology |
